Third course of Lemtrada improves MS patient’s relapse rate

A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis

Third course of Lemtrada improves MS patient’s relapse rate

Postby MSUK » Mon Mar 05, 2018 8:27 am

Study shows third course of Lemtrada improves MS patient’s relapse rate and disability

A study released at #ACTRIMS2018 has revealed that patients who experienced relapses after two courses of Lemtrada (alemtuzumab) showed improvement in relapse rate and disability progression after a third course of the drug…Read more - http://www.ms-uk.org/study-shows-third-course-lemtrada-improves-ms-patient%E2%80%99s-relapse-rate-and-disability

Image
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Return to Campath (Lemtrada, Alemtuzumab)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service